Evolent Health, Inc. Accretion Expense
Evolent Health, Inc. (EVH) reported Accretion Expense of $0 for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2018-08-09
- Evolent Health, Inc. accretion expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Evolent Health, Inc. accretion expense for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Evolent Health, Inc. accretion expense for the quarter ending 2017-06-30 was $48.00K.
- Evolent Health, Inc. accretion expense for the quarter ending 2017-03-31 was $57.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month |
|---|---|---|
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |
| 2017-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $105.00K 10-Q · filed 2018-08-09 |
| 2017-03-31 | $57.00K 10-Q · filed 2018-05-10 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |